News

Unwired Planet International Ltd v Huawei Technologies Ltd, Samsung Electronics Co Ltd and others [2016] EWHC 576 (Pat)22 March 2016Adrian Speck QC, Mark Chacksfield and Tom Jones (instructed by EIP legal) recently appeared for Unwired Planet in the third of four technical trials (Trial C) concerning alleged infringement of patents held by Unwired Planet and said to be essential to various mobile telecommunications standards. The trial concerned the alleged infringement of patent EP (UK) […]
8 New Square invite Dr Eleonora Rosati to be a Door Tenant15 March 2016Chambers are delighted that Dr Eleonora Rosati, an Italian Qualified lawyer has accepted their invitation to be a Door Tenant at 8 New Square. Admitted to the Florence Bar, Eleonora is a lecturer in IP at the University of Southampton, a guest lecturer in copyright law at EDHEC Business school (Ecole des Hautes Etudes Commerciales […]
Nekoti Limited -and- Univilla Limited t/a Consol [2016] EWHC 556 (Ch)15 March 2016Quentin Cregan (instructed by TLT LLP) acted for the Defendant in its successful application to strike out the Claimant’s particulars of claim with indemnity costs. The Claimant was a software developer who had supplied software to the Defendant. The Claimant issued proceedings in November 2013 wide ranging and extensive damages and/or an account of profits […]
Actavis UK Ltd and others v Eli Lilly & Company [2016] EWHC 234 (Pat) 12 February 201612 February 2016Richard Meade QC and Isabel Jamal, together with Thomas Raphael QC, successfully represented Actavis in the trial of the issues remitted by the Court of Appeal in Actavis v Lilly [2015] EWCA Civ 555. This action concerns Lilly’s European Patent No. 1 313 508 for the use of pemetrexed disodium, a chemotherapeutic treatment for lung […]
Regeneron Pharmaceuticals Inc v Kymab Ltd & Novo Nordisk A/S1 February 2016Michael Tappin QC, James Whyte and William Duncan appeared at the trial of this claim by Regeneron for infringement of its patent by Kymab’s antibody-producing transgenic mice. The subject-matter was described by the judge, Henry Carr J, as being of great technical complexity. In essence, the patent related to transgenic mice in which variable regions […]